- Report
- July 2024
- 175 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- March 2025
- 269 Pages
Global
From €5345EUR$5,600USD£4,478GBP
- Report
- March 2025
- 391 Pages
Global
From €5345EUR$5,600USD£4,478GBP
- Report
- March 2025
- 376 Pages
Global
From €5201EUR$5,450USD£4,358GBP
- Report
- March 2025
- 175 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- March 2025
- 175 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- December 2024
- 175 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- October 2024
- 190 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- November 2024
- 150 Pages
Global
From €4629EUR$4,850USD£3,878GBP
- Report
- August 2024
- 150 Pages
Global
From €4629EUR$4,850USD£3,878GBP
- Report
- May 2024
- 130 Pages
Global
From €3770EUR$3,950USD£3,159GBP
- Report
- July 2024
- 100 Pages
Global
From €3579EUR$3,750USD£2,999GBP
- Report
- January 2025
- 180 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- July 2024
- 120 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- October 2024
- 200 Pages
Global
From €3579EUR$3,750USD£2,999GBP
- Report
- May 2024
- 176 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- June 2024
- 183 Pages
Global
From €4295EUR$4,500USD£3,598GBP

Live attenuated vaccines are a type of vaccine that use a weakened form of a virus or bacteria to stimulate an immune response. These vaccines are designed to replicate the natural infection process, allowing the body to develop immunity without the risk of serious illness. Live attenuated vaccines are typically administered orally or nasally, and are often used to protect against diseases such as measles, mumps, rubella, and rotavirus.
Live attenuated vaccines are generally considered to be safe and effective, and are often used in combination with other vaccines to provide broader protection. They are also cost-effective, as they require fewer doses than other types of vaccines.
Notable companies in the live attenuated vaccine market include Merck & Co., GlaxoSmithKline, Sanofi Pasteur, Pfizer, and Novartis. Show Less Read more